J.P. Morgan Reiterates Overweight And PT Of $51 On Metlife (MET)

J.P. Morgan reiterated its Overweight rating and price target of $51 on Metlife MET in a research report published today. In the report, J.P. Morgan states, "We maintain our Overweight rating and 12/31/11 price target of $51. In our view, MET's superior franchise, strong operating fundamentals, and ROE expansion will drive an expansion in its P/BV multiple. Modest expected sales in the domestic business and overly positive investor sentiment are our primary concerns." In today's trading, Metlife lost 2.69% and currently stands at $44.91.